TickerFacts.

Nexalin Technology, Inc. (NXL): Shareholders' Equity

Annual figures by period end, from SEC filings.

$3.75M
As of 2025-12-31
$1.52M
As of 2026-06-30
-11.9%
3-year compound annual growth
$5.48M2021-12-31: -$1.68M2022-12-31: $5.48M2023-12-31: $3.21M2024-12-31: $3.68M2025-12-31: $3.75M$3.75M
2021-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$3.75M+2.0%2026-03-25, Balance as of period end
2024-12-31$3.68M+14.6%2026-03-25, Balance as of period end
2023-12-31$3.21M-41.5%2025-09-23, Balance as of period end
2022-12-31$5.48Mn/m2024-03-27, Balance as of period end
2021-12-31-$1.68Mn/a2023-03-27, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Nexalin Technology, Inc. (NXL)2025-12-31$3.75M+2.0%
Positron Corp (POSC)2025-12-31$1.44Mn/m
iTonic Holdings Ltd (ITOC)2025-12-31$6.12M-1.0%
Guided Therapeutics Inc (GTHP)2025-12-31-$6.01Mn/m
Hongchang International Co., Ltd (HCIL)2024-12-31$38.77M-4.2%
ADM Tronics Unlimited, Inc. (ADMT)2026-03-31$571.0K-15.0%
Neuraxis, Inc (NRXS)2025-12-31$3.40M+64.4%
Yubo International Biotech Ltd (YBGJ)2025-12-31-$1.95Mn/m
Nuwellis, Inc. (NUWE)2025-12-31$2.62M-59.8%

Compare NXL, POSC, ITOC, GTHP side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗